PeptiStrong for Muscle Strength Enhancement
Trial Summary
What is the purpose of this trial?
This trial tests if the PeptiStrong supplement can improve muscle strength and endurance in healthy young men and women when combined with regular exercise.
Will I have to stop taking my current medications?
The trial does not specify if you must stop taking your current medications, but it does require you to maintain your current lifestyle habits, including medications, as much as possible. However, if you are taking medications that may affect muscle mass, strength, or metabolism, you may need to stop, as assessed by the study's qualified investigator.
How does PeptiStrong differ from other muscle strength treatments?
PeptiStrong may be unique due to its potential use of oligopeptides, which have been shown to improve endurance performance in other contexts, suggesting a novel approach to enhancing muscle strength. Additionally, if PeptiStrong uses a nasal delivery system with cellulose derivatives, it could offer enhanced absorption and retention compared to traditional oral or injectable treatments.12345
Eligibility Criteria
This trial is for men and women aged 19-40 with a BMI of 18.5 to 29.9, who are willing to follow an exercise program three times a week without engaging in other vigorous activities two days before testing. Participants should maintain their current lifestyle, including diet and sleep patterns, avoid NSAIDs and alcohol before visits, and use contraception if necessary.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive PeptiStrong or placebo supplementation in conjunction with an exercise program for 56 days
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- PeptiStrong
- Placebo SMCC silicated micro-crystalline cellulose
Find a Clinic Near You
Who Is Running the Clinical Trial?
Nuritas Ltd
Lead Sponsor